Facilitating access to world-class industry skills in R&D



Making world-class expertise, facilities, complex technologies, and advanced analytics accessible to drive informed decisions.

Improved access to R&D skills is needed; innovators need more ready access to scarce industry-class skills and expertise across project validation and critical-path R&D planning.

Without it, it can lead to inappropriate decisions that cause delays, damage the value of the drug candidates, and deliver low-value un-investible offerings to private sector funders.

We provide world-class expertise and know-how in drug discovery R&D to innovators. We assess and create high-quality critical path R&D programmes to deliver novel drug candidates.







Case studies



Fast forward to the future of biomolecule analysis

Biomarkers Health Data SMi Virtual R&D

A lesson in Life Sciences

Community UK Life Sciences
Pupils in a lab

Harnessing the power of naturally-protective antibodies

Alchemab Cellular Sciences Neuroscience






Explore another area